What Do Trump’s New H-1B Rules Mean For Infosys, Cognizant, And Accenture?
The White House has issued a new proclamation on protecting American jobs, placing significant restrictions on the H-1B visa program. Effective from September 21, 2025, at 12:01 a.m. EDT, companies must pay $100,000 per year for every H-1B visa. This dramatic policy shift comes amid rising criticism that US corporations have been laying off domestic employees while continuing to hire thousands of H-1B workers from overseas. The announcement has shaken investor confidence, particularly in IT services firms like Infosys, Cognizant, and Accenture, which rely heavily on the H-1B program to deploy skilled talent in the United States.
About Infosys And Its Exposure
Infosys (NSE: INFY, NYSE: INFY) generates more than 60% of its revenues from North America. With thousands of employees currently on H-1B visas, Infosys faces a direct cost surge if these new fees are enforced. The company will either have to absorb higher operating expenses, renegotiate client contracts, or accelerate local hiring in the US. For investors, the immediate concern is margin compression and potential revenue growth constraints in its largest market.
Details Of The White House Proclamation
The proclamation cites national security and wage protection as the rationale for reforming the H-1B system. Some examples highlight the scale of reliance:
- One US firm received 5,189 H-1B approvals in FY25 while laying off 16,000 American workers.
- Another firm secured 1,698 H-1B approvals even as it cut 2,400 jobs in Oregon.
- A third company reduced its US workforce by 27,000 since 2022 while receiving 25,075 H-1B approvals.
- Another cut 1,000 jobs in February 2025 but was approved for 1,137 H-1B hires.
Impact On Cognizant And Accenture
Cognizant (NASDAQ: CTSH) is among the most heavily exposed, with one of the largest shares of H-1B visa workers. The new fee structure could severely hurt its profitability and force strategic restructuring. Accenture (NYSE: ACN), while more diversified geographically, still faces challenges in staffing US projects efficiently. Both companies may need to accelerate automation and nearshoring strategies in Latin America and Eastern Europe to reduce dependency on the H-1B system.
Wider Industry And Economic Implications
The tech sector is not alone in facing disruptions. Universities, healthcare providers, and research institutions also depend on H-1B workers. A sharp rise in visa costs could lead to labor shortages in critical fields, slowing innovation and productivity. For the stock market, this translates into potential volatility in IT stocks, education services companies, and healthcare staffing firms.
Mid-Article Investor Lens
Investors must consider both short-term stock declines and long-term structural shifts. The market is already pricing in uncertainty, and legal challenges could further complicate implementation timelines. Monitoring quarterly guidance from Infosys, Cognizant, and Accenture will be essential in gauging real financial impact.
Investor Takeaway
Trump’s sweeping H-1B reforms represent a watershed moment for IT services. Infosys and Cognizant are among the most vulnerable, while Accenture may weather the storm somewhat better due to diversification. Investors should expect volatility as the courts and companies respond. While this policy may be aimed at protecting American jobs, its ripple effects on innovation, competitiveness, and global outsourcing trends could be profound. Long-term, companies that adapt through automation and local talent pipelines will emerge stronger, but the near-term risks to stock performance are significant.
Stay updated on policy-driven market shifts at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
